Speaking at an interaction with Chief Ministers on the emerging COVID-19 situation in the country, PM Modi asserted that it is clear that the threat of...
The survey covered 5,971 vaccinated people, of which 24 per cent were aged below 40 and 50 per cent belonged to the 40-59 age group
Drugs Controller General of India (DCGI) has granted emergency use authorization for Corbavex and Covaxin for children
The study led by Dr Rajeev Jayadevan, co-chairman of the Indian Medical Association's national task force on coronavirus, said that 45 per cent of the vaccinated...
The most common ongoing long-COVID symptoms were fatigue, muscle pain, physically slowing down, poor sleep, and breathlessness
When vaccinated and unvaccinated people mixed, a substantial number of new infections would occur in vaccinated people, even in scenarios where immunisation rates were high, found...
Dr SK Sarin, Director, Institute of Liver and Biliary Sciences tells NDTV why booster doses are important and what can be expected going ahead
All those above the age of 18 who have completed nine months after the administration of the second dose are eligible for the precaution dose
According to Adar Poonawalla, CEO, Serum Institute of India, the Covishield booster dose will cost Rs. 600 plus tax
Drugs Controller General of India (DCGI) has granted EUA to Covovax, a protein-based COVID-19 vaccine for adolescents aged 12-17 years
All other currently approved COVID-19 vaccines in India require two doses of administration whereas Sputnik Light is a single dose
The National Technical Advisory Group on Immunisation (NTAGI) has not yet suggested any change in the schedule of Bharat Biotech's Covaxin, whose second dose is administered...